Nothing Special   »   [go: up one dir, main page]

Gröne et al., 1999 - Google Patents

Met‐RANTES reduces vascular and tubular damage during acute renal transplant rejection: blocking monocyte arrest and recruitment

Gröne et al., 1999

View PDF @Full View
Document ID
12030415047357730943
Author
Gröne H
Weber C
Weber K
Gröne E
Rabelink T
Klier C
Wells T
Proudfoot A
Schlondorff D
Nelson P
Publication year
Publication venue
The FASEB journal

External Links

Snippet

Chemokines are thought to contribute to the cellular infiltrate characteristic of renal transplant rejection. We show that Met‐RANTES, a chemokine receptor antagonist, suppresses recruitment of inflammatory cells into renal allografts. In a renal transplant model …
Continue reading at faseb.onlinelibrary.wiley.com (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Similar Documents

Publication Publication Date Title
Gröne et al. Met‐RANTES reduces vascular and tubular damage during acute renal transplant rejection: blocking monocyte arrest and recruitment
Miura et al. Monokine induced by IFN-γ is a dominant factor directing T cells into murine cardiac allografts during acute rejection
Morita et al. Early chemokine cascades in murine cardiac grafts regulate T cell recruitment and progression of acute allograft rejection
Noronha et al. In situ production of TNF-α, IL-1β and IL-2R in ANCA-positive glomerulonephritis
Murai et al. Active participation of CCR5+ CD8+ T lymphocytes in the pathogenesis of liver injury in graft-versus-host disease
Hancock et al. Donor-derived IP-10 initiates development of acute allograft rejection
Adams et al. HEPATIC EXPRESSION OF MACROPHAGE INFLAMMATORY PROTEIN-1α AND MACROPHAGE INFLAMMATORY PROTEIN-1β AFTER LIVER TRANSPLANTATION1
Lo et al. Differential regulation of CCL21 in lymphoid/nonlymphoid tissues for effectively attracting T cells to peripheral tissues
Segerer et al. The Duffy antigen receptor for chemokines is up-regulated during acute renal transplant rejection and crescentic glomerulonephritis
Yin et al. SDF-1α involved in mobilization and recruitment of endothelial progenitor cells after arterial injury in mice
US20020018776A1 (en) Method of treating graft rejection using inhibitors of CXCR3 function
Kapoor et al. EARLY EXPRESSION OF INTERFERON-γ INDUCIBLE PROTEIN 10 AND MONOKINE INDUCED BY INTERFERON-γ IN CARDIAC ALLOGRAFTS IS MEDIATED BY CD8+ T CELLS1
Suzuki et al. Susceptibility to T cell-mediated injury in immune complex disease is linked to local activation of renin-angiotensin system: the role of NF-AT pathway
Wallis et al. Effector functions of endothelium in inflammatory and immunologic reactions
Mulligan et al. Role of RANTES in experimental cardiac allograft rejection
Hüser et al. CCR4‐deficient mice show prolonged graft survival in a chronic cardiac transplant rejection model
AU766595B2 (en) Chemokine receptor antagonist and cyclosporin in combined therapy
WO2001078707A1 (en) Treating graft rejection with ccr5 inhibitors
WO1996002265A1 (en) The cellular basis of transplant arteriosclerosis
Koga et al. CD8+ T CELLS PRODUCE RANTES DURING ACUTE REJECTION OF MURINE ALLOGENEIC SKIN GRAFTS1
Verbsky et al. Nonhematopoietic expression of Janus kinase 3 is required for efficient recruitment of Th2 lymphocytes and eosinophils in OVA-induced airway inflammation
Nelson et al. Biology, biochemistry and pathophysiology of the RANTES chemokine
Sho et al. Function of the vascular endothelial growth factor receptors Flt-1 and Flk-1/KDR in the alloimmune response in vivo
AU2862300A (en) Methods for preventing graft rejection and ischemia-reperfusion injury
Toh et al. Characterization of neutrophil activation by repeated injection of endotoxin in rabbits. Role of neutrophils in the generalized Shwartzman reaction